Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Is Underused as a Curative Therapy in Eligible Patients From the United States

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.06.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Outcomes From Unrelated Donor Hematopoietic Stem Cell Transplantation

Cancer Control
MedicineOncologyHematology
2011English

Successful Treatment of Griscelli Syndrome With Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2002English

Donor-Derived Myeloid Neoplasm Post Allogeneic Hematopoietic Cell Transplantation

Blood
BiochemistryImmunologyCell BiologyHematology
2017English

MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation

Science Translational Medicine
Medicine
2012English

Related Hematopoietic Cell Donor Care: Is There a Role for Unrelated Donor Registries?

Bone Marrow Transplantation
TransplantationHematology
2015English

Outcomes of Related and Unrelated Donor Searches Among Patients With Primary Immunodeficiency Diseases (PIDs) Referred for Allogeneic Hematopoietic Cell Transplantation (HCT)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Unrelated Donor Stem Cell Transplantation in Adult Patients With Thalassemia

Bone Marrow Transplantation
TransplantationHematology
2005English

HLA-DPA1 Mismatch Is Associated With Decreased Overall Survival Following Unrelated Donor Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Haematologica
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy